NSE: BIOCON | BSE: 532523

Mid-range Performer

Download real time

349.40 -4.05 (-1.15%)

850.9K NSE+BSE Volume

NSE 13 Oct, 2025 3:31 PM (IST)

46,713.5

Market Cap

Market Leader

1.2

Beta 1Year

Very High Volatility

US FDA Observation

Biocon's New Jersey manufacturing facility receives Form 483 with one observation from the US FDA See details

Biocon Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for BIOCON, BSE:532523 Biocon Ltd.

Is Biocon Ltd. worth buying?

728 Votes:

Buy 75.0%

Sell 16.35%

Hold 8.65%

RESEARCH REPORTS

Sell SEE REPORTS >

Buy SEE REPORTS >